WO2024256539A1 - Improvements in or relating to organic compounds - Google Patents

Improvements in or relating to organic compounds Download PDF

Info

Publication number
WO2024256539A1
WO2024256539A1 PCT/EP2024/066361 EP2024066361W WO2024256539A1 WO 2024256539 A1 WO2024256539 A1 WO 2024256539A1 EP 2024066361 W EP2024066361 W EP 2024066361W WO 2024256539 A1 WO2024256539 A1 WO 2024256539A1
Authority
WO
WIPO (PCT)
Prior art keywords
malodour
microparticles
antiperspirant
perfumery
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2024/066361
Other languages
French (fr)
Inventor
Matthew Peter Brooks
Emmanuel Aussant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Priority to EP24732957.6A priority Critical patent/EP4727515A1/en
Priority to CN202480039342.6A priority patent/CN121311213A/en
Priority to KR1020267001283A priority patent/KR20260022456A/en
Publication of WO2024256539A1 publication Critical patent/WO2024256539A1/en
Priority to MX2025014653A priority patent/MX2025014653A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87Polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Definitions

  • the present invention is concerned with consumer products containing a malodour-reducing composition comprising a zinc carboxylate, and the use of such products to suppress or eliminate malodours on a surface containing a source of malodour.
  • malodour-counteracting agents that chemically modify malodorous molecules to create non- odorous reaction products
  • malodour-counteracting agents that have anti-microbial activity to exert an effect on microbes that may act as precursors in the development of malodour.
  • successful intervention usually relies upon the delivery of sufficiently high dosages of malodour- counteracting agents to a surface containing the sources of malodour, and retaining them on the surface for a time period sufficient to enable them to exert a malodour counteracting effect.
  • Zinc salts including certain zinc carboxylates, are known to reduce or inhibit malodour, both by chemical and anti-bacterial means.
  • Zinc neodecanoate in particular, has been described as being useful as a malodour reducing active agent in anhydrous deodorant compositions, see WO2018/087147 and WO2018/087148.
  • zinc neodecanoate has proven to be an effective malodour counteracting agent when delivered from the deodorant products referred to above, applicant found that it was difficult to incorporate it into products containing appreciable levels of water. Attempts to incorporate zinc neodecanoate into such products leads to the development of solid residues that can be problematic both in terms of the ease of manufacture of the products as well as their ease of use in application. More specifically, the formation of unwanted residues can cause fouling on production lines. It is also the case that during use residues can interfere with the proper dispensing of a product from its container, preventing the continuous and uniform delivery of effective amounts of zinc neodecanoate onto a surface in need of treatment.
  • malodour-reducing compositions containing a zinc carboxylate, and in particular zinc neodecanoate that can be stably incorporated into consumer products containing water, and which as a result can be delivered from a consumer product onto a surface containing a source of malodour thereby to deliver a perceivable malodour-reducing effect.
  • the invention provides in a first aspect a malodour-reducing composition
  • a malodour-reducing composition comprising a zinc carboxylate and means for dissolving or dispersing the zinc carboxylate in a consumer product containing water, said means comprising at least one perfume ingredient, perfumery solvent, surfactant or mixtures thereof, and/or encapsulating media comprising a plurality of microparticles for encapsulating the zinc carboxylate.
  • the invention provides a consumer product, comprising the malodour-reducing composition according to the first aspect of the invention.
  • the invention provides a method of incorporating a zinc carboxylate into a consumer product comprising water, the method comprising the step of mixing the zinc carboxylate with at least one perfume ingredient, perfumery solvent or surfactant, and/ or encapsulating medium comprising a plurality of microparticles for encapsulating the zinc carboxylate.
  • the invention provides a method of delivering a malodour counteracting effect to a surface containing a source of malodour, said method comprising the step of delivering a malodour- reducing composition according to the first aspect of the invention to the surface from a consumer product comprising water.
  • the applicant has discovered in a surprising manner that despite the poor solubility or dispersibility of zinc carboxylates, and in particular zinc neodecanoate, in consumer products containing appreciable levels of water, the combination of a zinc carboxylate with perfume ingredients, perfumery solvents, surfactants and/or encapsulation media as more fully described herein, enable the preparation of malodour-reducing compositions that can be stably incorporated into such consumer products.
  • a zinc carboxylate and in particular zinc neodecanoate, can be incorporated into such a consumer product whilst avoiding undesirable interactions that can result in the formation of solid residues.
  • the zinc carboxylate remains uniformly dissolved or dispersed it is possible to deliver a measured and effective concentration of zinc carboxylate uniformly over a surface containing a source of malodour deliver perceivable malodour-reducing performance.
  • the applicant also surprisingly found that by carefully selecting the carboxylate ligand as described more fully herein, the zinc carboxylate can exhibit excellent film-forming properties on a surface and resist rinse-off.
  • the zinc carboxylate useful in the malodour-reducing composition is selected on the basis of its ability to exert an effective malodour-reducing effect on a surface containing a source of a malodour, when delivered from a consumer product containing appreciable amounts of water.
  • Relevant considerations in the selection include the solubility or dispersibility of the zinc carboxylate in an oil phase containing one or more of a perfumery solvent, a perfume ingredient, surfactants or mixtures thereof, and/or an encapsulating medium comprising a plurality of microparticles. The higher the solubility or dispersibility of the zinc carboxylate in an oil phase containing one or more of these ingredients, the higher can be its concentration in the malodour-reducing composition.
  • Zinc carboxylates having a carbon chain length of 1 to 3 carbon atoms are very water soluble and not compatible in perfumery solvents and perfume ingredients, and are not preferred as such. Those zinc carboxylates having a carbon chain length of 1 to 7 carbon atoms tend to have a pungent or even unpleasant odour and are likewise not preferred. However, zinc carboxylates, wherein the carboxylate group has between 8 and 12 carbon atoms are preferred as they have optimum malodour reduction performance, have a low volatility and also have low or no odour. Most preferred of the zinc carboxylates is zinc neodecanoate. Zinc neodecanoate and methods for its preparation, for example from zinc oxide and the corresponding carboxylic acid, are well known in the art.
  • a malodour-reducing composition is considered to be capable of being stably incorporated in a consumer product for the purpose of the present invention if the composition, by means of the inclusion therein of mixtures of perfumery ingredients, solvents, surfactants, and/or the use of an encapsulation medium, will readily disperse or dissolve in a consumer product, without causing undesirable changes in the physical characteristics of the consumer product, such as the development of residues, that could adversely affect the delivery of a zinc carboxylate consistently and uniformly to a surface in need of treatment.
  • Suitable perfumery solvents include, but are not limited to isopropyl myristate, ethanol, cyclomethicone, glycol ethers, such as dipropylene glycol methyl ether (e.g. Dowanol DPM) or tripropylene glycol methyl ether (Dowanol TPM), Medium Chain Triglycerides (MCTs), such as those sold under the trade names Miglyol, e.g Miglyol 812, methyl esters of hydrogenated wood rosin, such as Hercolyn DW, isoparaffins, such as the Isopar solvents, benzyl salicylates, and cyclohexyl salicylates.
  • glycol ethers such as dipropylene glycol methyl ether (e.g. Dowanol DPM) or tripropylene glycol methyl ether (Dowanol TPM), Medium Chain Triglycerides (MCTs), such as those sold under the trade names Miglyol
  • Suitable perfumery ingredients can be selected from the palette of available ingredients, and may be selected on the basis of the particular hedonic effect that is desired or any functional effect that is required, such as a malodour-reducing effect.
  • Perfumery ingredients include but are not limited to 3,7- dimethyloct-6-enal, e.g. Citronellal; 3,7-dimethyloct-6-en-l-ol, e.g. Citronellol; 2,4-dimethylcyclohex-3- enecarbaldehyde, e.g. Cyclal C; (E)-dec-4-enal; ethyl 2-methyl butyrate; 1-phenylethyl acetate, e.g.
  • Lemonile 3,7- dimethylocta-l,6-dien-3-ol, e.g. Linalool; 2,6-dimethylhept-5-enal, e.g. Melonal; methyl amyl ketone; methyl benzoate; methyl heptenone; methyl hexyl ketone; phenyl ethyl acetate; tetrahydro myrcenol; Patchouli Oil; tridecen-2-nitrile; 6-methoxy-2,6-dimethyloctanal, e.g. Calypsone; 5-tert-butyl-2-methyl- 5-propyl-2H-furan, e.g.
  • the perfumery ingredients may comprise at least 2, at least 3, at least 4, at least 5 of the following ingredients: 3,7-dimethyloct-6-enal, e.g. Citronellal; , 3,7- dimethyloct-6-en-l-ol, e.g. Citronellol; 2,4-dimethylcyclohex-3-enecarbaldehyde, e.g. Cyclal C; (E)-dec- 4-enal; Ethyl 2-methyl butyrate; 1-phenylethyl acetate, e.g.
  • Tricyclal and optionally at least 2, at least 3, at least 4, at least 5 of the following ingredients: 2,6,10- trimethylundec-9-enal, e.g. Adoxal; Armoise oil Morocco; 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline, e.g. Bigaryl; (2E)-3-phenylprop-2-enal, e.g. Cinnamic aldehyde; (E)-3,7-dimethylocta-2,6-dienal, e.g. Citral; Ethyl caproate; l,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, e.g.
  • 2,6,10- trimethylundec-9-enal e.g. Adoxal
  • Armoise oil Morocco 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline, e.g. Bigaryl
  • Eucalyptol Eucalyptus, e.g. globulus oil China; l-(l,2,8,8-tetramethyl-l,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, e.g. Georgywood; Hexyl isobutyrate; (E)-4-(2,6,6-trimethylcyclohex-l-en-l-yl)but-3-en-2-one, e.g.
  • Ionone beta Isobutyl isobutyrate; Isobutyl quinolone; Isopropyl methyl-2-butyrate; (2E,6Z)-3,7-dimethylnona-2,6-enitrile, e.g. Lemonile; 3,7-dimethylocta-l,6-dien-3-ol, e.g. Linalool; 2,6-dimethylhept-5-enal, e.g.
  • Preferred perfumery ingredients include ambrofix (dodecahydro-3a,6,6,9a-tetramethyl naphtho[2,l- b]furan), radjanol (2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-en-l-ol), benzyl salicylate, cis-3- hexenyl salicylate, coumarin, cyclamen aldehyde, dihydrojasmonate, hedione (methyl dihydrojasmonate), lilial (3-(4-tert-butylphenyl)-2-methylpropanal), nympheal (3-(4-isobutyl-2- methylphenyl)propanal), methyl ionone, phenyl ethyl phenyl acetate, tetrahydrogeranyl acetate, trimofix (reaction products of acetic anhydride and l,5,10
  • the malodour-reducing composition comprises zinc neodecoate in a mixture with a perfumery solvent, or a perfumery ingredient or a mixture thereof. More particularly, the mixture may comprise greater than 50 wt %, greater than 60 wt %, greater than 70 wt %, greater than 80 wt % of zinc neodecanoate. More particularly still, the malodour-reducing composition comprises about 80 wt % zinc neodecanoate and about 20 wt % of at least one perfumery solvent or at least one perfumery ingredient or mixtures thereof.
  • the malodour-reducing composition described herein above is in the form of a plurality of microparticles encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
  • the malodour-reducing composition is in the form of a powder comprising a plurality of microparticles encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
  • the microparticles contain at least 30 wt %, at least 40 wt %, at least 50 wt %, at least 60 wt %, at least 70 wt %, at least 80 wt % of zinc neodecanoate based on the total weight of the microparticles.
  • the malodour-reducing composition can be added to the aforementioned consumer products at levels such as to deliver an effective malodour-reducing effect onto a surface in need of treatment.
  • the malodour-reducing composition in the form of a powder comprising a plurality of microparticles described above can incorporated into an antiperspirant product in an amount ranging from about 1 wt % to about 50 wt %, more particularly about 1 wt % to about 20 wt %, more particularly about 1 wt % to about 10 wt %, based on the total weight of the antiperspirant product.
  • the zinc neodecanoate is present in an amount of 0.1 to 20 wt %, more particularly still about 0.5 to 10 wt %, more particularly still 0.5 to 5 wt %, e.g. about 4 wt %, based on the total weight of the product.
  • Microparticles are small particles, having diameters ranging generally from about 1 to 1000 microns. Microparticles may have variety of structures ranging from single-core (so-called core-shell microparticles) to multi-cores, and can comprise single or multilayer shells.
  • the core material can comprise a zinc carboxylate and any other desired ingredient, such as one or more perfume ingredients or perfumery solvents, or surfactants.
  • Microparticles may be incorporated into a consumer product in the form of an aqueous slurry in which the microparticles are suspended.
  • the microparticles may be incorporated into a consumer product in the form of a powder.
  • Such powders can be formed by dehydrating a slurry for example by spray drying. Methods of forming microparticle slurries or dehydrated microparticles in powder format are well known in the art, and examples of such methods are disclosed in the references cited herein below, all of which are incorporated into the specification by reference.
  • Microparticles in powder format are particularly useful for incorporation into antiperspirant products, and particularly aerosol antiperspirant products.
  • Microparticles can be formed from thermosetting polymers, such as melamine formaldehyde, melamine urea formaldehyde, polyurea, polyurethane and polyacrylates.
  • thermosetting polymers shells can be formed as shells by known polymerization methods, such as interfacial polymerization around droplets of core material. Examples of core shell microcapsules formed from thermosetting polymers that are useful in the preparation of encapsulated zinc carboxylates are disclosed in W02004/016234; W02006/056093; WO2007/137441; W02008/098387; W02009/100553;
  • Coacervation is a well-known method of forming microparticles, whereby colloids are caused to form and harden around droplets of core material. So-called simple coacervation uses a single hydrocolloid, whereas complex coacervation uses two hydrocolloids. Coacervate microparticles useful in the present invention are disclosed in W02015/150370; and WO2013/068581, which documents are herein incorporated by reference.
  • microparticles can be formed by spray drying an emulsion comprising a zinc carboxylate and other materials desired to be encapsulated, and shell forming polymers, such as starches, modified starches, celluloses and the like. Examples of such microparticles, and methods of preparing them, are disclosed in WO2020/149192; WO2015/189296; and W02020/201258 all of which documents are herein incorporated by reference.
  • the encapsulated material is dispersed in the form of a plurality of droplets or cores dispersed within an encapsulating polymer matrix.
  • the microparticles are core-shell microparticles.
  • a malodour-reducing composition in the form of a plurality of core-shell microcapsules can provide superior malodour control performance compared, for example, with the aforementioned microparticles comprising a plurality of droplets or cores dispersed within an encapsulating polymer matrix.
  • biodegradable microparticles and in particular biodegradable core-shell microparticles, that are free, or substantially free of microplastics, and such microparticles are useful to encapsulate zinc carboxylates, and more particularly zinc neodecanoate, in accordance with the present invention.
  • Biodegradable microparticles can be formed by a process of coacervation or complex coacervation using various proteins and/or polysaccharides. Examples of biodegradable microparticles useful in the present invention are disclosed in WO2020/233887, which is herein incorporated by reference.
  • thermosetting resin formed by the reaction of a polyfunctional isocyanate and an aminosilane
  • An encapsulated form of zinc carboxylate can also be presented in the form of a plurality of pastilles or prills, which can be formed when the zinc carboxylate is dissolved or dispersed in a water-soluble matrix material and the resultant mixture is shaped, for example by extrudation and cutting.
  • molten droplets of matrix material and zinc carboxylate can be dropped into a suitable liquid bath to harden the droplets and form prills, which can be collected by filtration.
  • the water soluble matrix can contain a variety of materials useful in the preparation of scent booster compositions, as are generally well known in the art.
  • a suitable matrix material would be a mixture of polyethylene glycol, a filler material, and optionally a clay or a salt or mixtures thereof. Such compositions are described in US2017/226690, which is herein incorporated by reference.
  • the zinc carboxylate, and optionally a perfume ingredient, perfumery solvent and a surfactant can be incorporated into the matrix material freely, or in an encapsulated form, as more fully described above.
  • Encapsulated forms of zinc carboxylate described hereinabove can also be incorporated into such water-soluble matrices.
  • a malodour-reducing composition may be formed by dissolving or dispersing a zinc carboxylate in an oil phase comprising a surfactant and optionally at least one perfumery ingredient and or perfumery solvent, or mixtures thereof.
  • the zinc carboxylates are to some extent soluble or miscible in perfumery ingredients or perfumery solvents, they are practically insoluble in water. Accordingly, in order to be able to disperse an effective concentration of a zinc carboxylate in a consumer product containing water, it is necessary to present the zinc carboxylate in admixture with a surfactant.
  • an antiperspirant product comprising an antiperspirant active ingredient and a malodour-reducing composition in the form of a plurality of microparticles, and more particularly core-shell microparticles, dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
  • the antiperspirant product comprises an antiperspirant active ingredient and a malodour-reducing composition in the form of a powder comprising a plurality of microparticles, and more particularly core-shell microparticles, dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
  • any of the malodour-reducing compositions described herein above can be used to stably incorporate zinc carboxylates, and in particular zinc neodecanoate, into any of the consumer product formats referred to in any of the embodiments described herein.
  • zinc neodecanoate can be incorporated into an antiperspirant product as defined herein in a method comprising the step of mixing zinc neodecanoate with at least one perfume ingredient or perfumery solvent and encapsulating the mixture in an encapsulating medium comprising a plurality of microparticles as described herein, and dispersing the microparticles in the antiperspirant product.
  • any of the malodour-reducing compositions described in any of the embodiments referred to herein can be delivered from any of the aforementioned consumer product formats and onto a surface containing a source of malodour where it can deliver a malodour-reducing effect.
  • Surfaces include human or animal skin or hair, or inanimate surfaces including all manner of household surfaces such as hard surfaces, floors, bathroom and toilets, dishes, cutlery and other kitchen utensils, fabrics and the like. Malodours found on such surfaces include malodours from food, body odours, and odours from the waste of humans and animals.
  • Sources of malodour include, but are not limited to personal malodours such as axillary sweat, foot malodour, feminine (vaginal) malodour, scalp/hair malodour, urine malodour, food waste malodour, indoor air malodour, malodour from mould and mildew, and laundry malodour.
  • personal malodours such as axillary sweat, foot malodour, feminine (vaginal) malodour, scalp/hair malodour, urine malodour, food waste malodour, indoor air malodour, malodour from mould and mildew, and laundry malodour.
  • a malodour reducing composition (1 wt % perfume, 19 wt % isopropyl myristate, and 80 wt % zinc neodecanoate) is encapsulated in melamine urea formaldehyde to form 1 Kg of slurry in accordance with the following method:
  • the malodour reducing composition was successfully produced in the form of a slurry of microparticles.
  • the emulsion was subjected to spray drying using a LabPlant SD-06 Spray Dryer.
  • the spray drying process parameters were as follows: Inlet Temperature: 190 °C; Outlet Temperature: 90 °C; peristaltic pump speed: 485 mL/h; and air flow rate: 3.7 m/s.
  • the resulting spray dried powder was mixed with silicon dioxide Aerosil 200 (0.5 g) in a closed mixing vessel.
  • a malodour-reducing composition was successfully produced in the form of a plurality of microparticles in dried powder form.
  • AEROSIL is a fumed silica (trade mark of Degussa); "Blanose” is carboxymethyl cellulose (trade mark of Hercules)).
  • Eriochrome Black T is a metallochromic indicator that can be used for complexometric titration with various metal ions. It is typically used with a pHlO buffer, whereupon the solution changes from a blue colour to red when forming a complex with a metal ion, such as zinc. The proportion of complexed Eriochrome Black T will determine the shade of the indicator solution. The presence of any uncomplexed indicator will remain blue, which can mask the red coloured complexed form. Therefore, it is important to use as little of the indicator as possible to make the test as sensitive as possible. However, this needs to be carefully balanced with using enough indicator to perceive any colour.
  • a series of solutions of zinc neodecanoate in ethanol were prepared (from 10% to 0.00001% in logarithmic steps).
  • a further series of vials were prepared with 2mL of pH 9.41 buffer solution and lOpL of Eriochrome Black T solution (1% in ethanol).
  • lOpL of the zinc neodecanoate solutions were added to the vials with the Eriochrome Black T solutions.
  • the colours of the resulting solutions demonstrate that zinc neodecanoate can be detected at concentrations of 0.1% and higher, with 0.01% producing a weakly positive result.
  • a malodour reducing composition (zinc neodecanoate @ 10 wt % in Dowanol TPM) is added to the scent booster composition described in Example 3, and mixed thoroughly. A sample only using Dowanol TPM and the scent booster composition was also prepared. 150mg of each scent booster composition was added to 50mL of distilled water in a 60g glass bottle. Four small pieces of terry towelling (totalling 14cm 2 ) were added to each bottle and placed on a roller for one hour.
  • the indicator solution was prepared by adding buffer solution (ImL, pH 9.21) and Eriochrome Black T solution (1% in ethanol) into a clear glass vials (7.5mL). One of the pieces of terry towelling from each bottle was added to separate vials containing the indicator solution. The vials were agitated and the resulting colour was recorded.
  • a clear and colourless model trigger spray formulation was prepared using zinc neodecanoate (0.75 wt %), Dowanol TPM as solvent (0.25 wt %), lutensol TO 10 (9 wt %) and water (90 wt %).
  • a control was prepared by replacing Dowanol TPM and zinc neodecanoate with diethyl phthalate (1 wt %)•
  • T-shirt inserts were pre-treated with the model formulation and the control. The inserts were allowed to dry and were placed into the underarm of t-shirts, which were then worn by a panel of volunteers for a whole day, without using fragranced products. Thereafter, the t-shirt inserts were olfactively assessed by a trained sensory panel for malodour intensity.
  • test compositions were prepared according to the composition given in table 1.
  • the samples NU67, MO48 and QC29 (lOOOpL) are applied to the centre of separate pieces of cloth (70mm x 70mm of terry towelling squares) together with 250pL of 0.006% 3-mercapto-3-methyl butan- l-ol (MMB) in Dowanol TPM as malodour.
  • Samples ED71 and WC14 are applied to the centre of separate pieces of cloth (70mm x 70mm of terry towelling squares) without any malodour as control. Labels were attached to the top right of each piece of fabric.
  • the pieces of fabric were assessed by a trained panel of 15 assessors for malodour intensity using a 0- 100 scale with the control set at 70, and 1-minute gap between assessments.
  • the samples were assessed in a randomised order (randomisation was produced using Design Express).
  • the average intensity rating for the hidden control (NU67) was 63.
  • Two refresher sprays were formulated, one with zinc neodecanoate, the other one without it. They were prepared by mixing each ingredient in the order presented in table 2, from top to bottom.
  • the T-shirts are then supplied to volunteers, who wear them for a working day without use of any fragranced products or deodorant.
  • the T-shirts are then returned for assessment the following day.
  • the inserts are removed from the T-shirts and arranged around two separate tables (one for left inserts, the other for the right inserts).
  • the geometric mean malodour intensity was calculated for each insert, along with the standard error and difference between left and right. Perceived malodour intensity was measured and the overall results are that, with a value of 42.5, the intensity of the pre-dosed T-shirt inserts with zinc neodecanoate was lower than the intensity of the T-shirt inserts without the zinc neodecanoate having a value of 45.2.
  • Two refresher sprays were formulated, one with zinc neodecanoate, the other one without it. They were prepared by mixing each ingredient in the order presented in table 4, from top to bottom.
  • the fabric inserts are pre-washed, de-sized, labelled, had poppers sewn-in and attached to the underarm area of white T-shirts (also pre-washed and de-sized).
  • the T-shirts are then supplied to volunteers who wear them for a working day without use of any fragranced products or deodorant. The T-shirts are then returned for further treatment and assessment.
  • the fabric inserts were pre-screened by a trained panel of three internal sensory assessors to ensure that there is a perceivable amount of malodour but no fragrance present on the inserts.
  • the fabric refresher formulations are applied to the remaining inserts: approximately 4 pumps of the selected fabric refresher.
  • a different fabric refresher is applied to either the left or right insert.
  • the inserts are then allowed to dry before attaching to the T-shirts, randomising which side had the technology present (+TECH) and which not (W/O) as shown in table 5.
  • the inserts are allowed to dry and then arranged in pairs for olfactive assessment.
  • the trained sensory panel assesses each insert for malodour intensity using a 0-100 free scoring scale in a randomised order defined by the assessment sheet.
  • the geometric mean malodour intensity was calculated for each insert, along with the standard error and difference between left and right. Perceived malodour intensity was measured and the overall results are that, with a value of 37.3, the intensity of the post-dosed T-shirt inserts with zinc neodecanoate was lower than the intensity of the T-shirt inserts without the zinc neodecanoate having a value of 44.4 (Fig. 2).
  • the socks were provided to volunteers (naive panellists) to be worn for a working day, then assessed for fragrance and malodour (0-10 fixed scale), and the preferred socks were selected.
  • a model aerosol base is selected based on its transparency that enables the development of any residues to be observed.
  • the base selected is 96 % ethanol, which allows easily observance of any precipitates that are formed.
  • Two glass jars containing aerosol formulations (50ml) are prepared by dispersing 1 and 4 wt% of core shell capsules according to Example 1 in ethanol 96° before addition of propellant.
  • Another two glass jars containing aerosol formulations are prepared by dispersing 0.5 wt% and 2 wt% of the malodour-reducing composition (this time in unencapsulated form), in ethanol before addition of propellant.
  • the glass jars are stored at 4°C for 24h.
  • the testing was performed on underarm through a self-assessment study in which the Control was applied on one side of a participant's underarm while Base 01 was applied on the other underarm.
  • a group of participants were recruited and instructed to take aerosol test products (i.e. Base 01 and Control) home for use.
  • a test study was rolled out over a period of 1 to 2 weeks. The objective of this test was to allow self-assessment of long lasting malodour protection on underarm contributed by the test products.
  • the overall perceived odour intensity was self-assessed using a 0 to 5 rating scale. Participants were instructed to smell directly the treated skin rather than through clothing worn over the treated skin in order to make an odour rating. For the evaluation stages conducted, each test product was assessed twice by each of the 21 participants, thus giving 42 assessments per test product. The participants used the following scaling:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Fats And Perfumes (AREA)

Abstract

The present invention relates to the stable incorporation of malodour-reducing composition containing zinc neodecanoate into a consumer product containing water, and the delivery of zinc neodecanoate from the consumer product onto a surface containing a source of malodour and to deliver a sensorially perceptible malodour reduction effect to the surface.

Description

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
Field of the Invention
The present invention is concerned with consumer products containing a malodour-reducing composition comprising a zinc carboxylate, and the use of such products to suppress or eliminate malodours on a surface containing a source of malodour.
Background of the invention
Human olfaction is complex, and how malodours are perceived can be influenced by many factors. However, the most important factor in sensing, and indeed eliminating malodours is the vapour phase concentration of the malodorous molecules. Suppression or elimination of malodour can be achieved by the use of malodour-counteracting agents that chemically modify malodorous molecules to create non- odorous reaction products; or by using malodour-counteracting agents that have anti-microbial activity to exert an effect on microbes that may act as precursors in the development of malodour. In either case, successful intervention usually relies upon the delivery of sufficiently high dosages of malodour- counteracting agents to a surface containing the sources of malodour, and retaining them on the surface for a time period sufficient to enable them to exert a malodour counteracting effect.
Zinc salts, including certain zinc carboxylates, are known to reduce or inhibit malodour, both by chemical and anti-bacterial means. Zinc neodecanoate, in particular, has been described as being useful as a malodour reducing active agent in anhydrous deodorant compositions, see WO2018/087147 and WO2018/087148.
Although zinc neodecanoate has proven to be an effective malodour counteracting agent when delivered from the deodorant products referred to above, applicant found that it was difficult to incorporate it into products containing appreciable levels of water. Attempts to incorporate zinc neodecanoate into such products leads to the development of solid residues that can be problematic both in terms of the ease of manufacture of the products as well as their ease of use in application. More specifically, the formation of unwanted residues can cause fouling on production lines. It is also the case that during use residues can interfere with the proper dispensing of a product from its container, preventing the continuous and uniform delivery of effective amounts of zinc neodecanoate onto a surface in need of treatment.
The difficulty of formulating zinc carboxylates, and zinc neodecanoate in particular, in consumer products that contain appreciable amounts of water currently prevents the wider application of this effective technology to create sensorially perceivable malodour-reducing effects across a wide range of consumer product formats.
Summary of the invention
There remains a need to provide malodour-reducing compositions containing a zinc carboxylate, and in particular zinc neodecanoate, that can be stably incorporated into consumer products containing water, and which as a result can be delivered from a consumer product onto a surface containing a source of malodour thereby to deliver a perceivable malodour-reducing effect. i The invention provides in a first aspect a malodour-reducing composition comprising a zinc carboxylate and means for dissolving or dispersing the zinc carboxylate in a consumer product containing water, said means comprising at least one perfume ingredient, perfumery solvent, surfactant or mixtures thereof, and/or encapsulating media comprising a plurality of microparticles for encapsulating the zinc carboxylate.
In a second aspect, the invention provides a consumer product, comprising the malodour-reducing composition according to the first aspect of the invention.
In a third aspect, the invention provides a method of incorporating a zinc carboxylate into a consumer product comprising water, the method comprising the step of mixing the zinc carboxylate with at least one perfume ingredient, perfumery solvent or surfactant, and/ or encapsulating medium comprising a plurality of microparticles for encapsulating the zinc carboxylate.
In a fourth aspect, the invention provides a method of delivering a malodour counteracting effect to a surface containing a source of malodour, said method comprising the step of delivering a malodour- reducing composition according to the first aspect of the invention to the surface from a consumer product comprising water.
The details, examples and preferences provided in relation to any one or more of the stated aspects or embodiments of the present invention will be further described herein and apply equally to all aspects and embodiments of the present invention. Any combination of embodiments, examples and preferences described herein in all possible variations thereof are encompassed by the present invention unless otherwise indicated herein, or otherwise clearly contradicted by context.
Description of the Figures
Figure 1. Perceived malodour intensity - results illustrating example 6 A
Figure 2. Perceived malodour intensity of post-dosed refresher spray formulation on worn T-shirt inserts - results illustrating example 6 C
Figure 3. Perceived intensity of malodour or fragrance - results illustrating example 6 D
Detailed Description of the Invention
The applicant has discovered in a surprising manner that despite the poor solubility or dispersibility of zinc carboxylates, and in particular zinc neodecanoate, in consumer products containing appreciable levels of water, the combination of a zinc carboxylate with perfume ingredients, perfumery solvents, surfactants and/or encapsulation media as more fully described herein, enable the preparation of malodour-reducing compositions that can be stably incorporated into such consumer products.
In accordance with the invention, a zinc carboxylate, and in particular zinc neodecanoate, can be incorporated into such a consumer product whilst avoiding undesirable interactions that can result in the formation of solid residues. By ensuring the zinc carboxylate remains uniformly dissolved or dispersed it is possible to deliver a measured and effective concentration of zinc carboxylate uniformly over a surface containing a source of malodour deliver perceivable malodour-reducing performance. Furthermore, the applicant also surprisingly found that by carefully selecting the carboxylate ligand as described more fully herein, the zinc carboxylate can exhibit excellent film-forming properties on a surface and resist rinse-off.
In the first aspect of the invention the zinc carboxylate useful in the malodour-reducing composition is selected on the basis of its ability to exert an effective malodour-reducing effect on a surface containing a source of a malodour, when delivered from a consumer product containing appreciable amounts of water. Relevant considerations in the selection include the solubility or dispersibility of the zinc carboxylate in an oil phase containing one or more of a perfumery solvent, a perfume ingredient, surfactants or mixtures thereof, and/or an encapsulating medium comprising a plurality of microparticles. The higher the solubility or dispersibility of the zinc carboxylate in an oil phase containing one or more of these ingredients, the higher can be its concentration in the malodour-reducing composition. Other considerations include the ability of the zinc carboxylate to disperse in a medium containing appreciable levels of water and deposit uniformly from it onto a surface to be treated; its ability to adhere to the surface once deposited; as well as its volatility. Zinc carboxylates that deposit well, which are adherent to a surface to be treated and which do not evaporate quickly from the surface once deposited will, self-evidently, be able to exert a longer and more effective malodour-reducing effect. Another important consideration is the odour of the zinc carboxylate. For obvious reasons, it is undesirable if a malodour-reducing compositions contains an active ingredient that is itself a source of malodour.
Zinc carboxylates having a carbon chain length of 1 to 3 carbon atoms are very water soluble and not compatible in perfumery solvents and perfume ingredients, and are not preferred as such. Those zinc carboxylates having a carbon chain length of 1 to 7 carbon atoms tend to have a pungent or even unpleasant odour and are likewise not preferred. However, zinc carboxylates, wherein the carboxylate group has between 8 and 12 carbon atoms are preferred as they have optimum malodour reduction performance, have a low volatility and also have low or no odour. Most preferred of the zinc carboxylates is zinc neodecanoate. Zinc neodecanoate and methods for its preparation, for example from zinc oxide and the corresponding carboxylic acid, are well known in the art.
A malodour-reducing composition is considered to be capable of being stably incorporated in a consumer product for the purpose of the present invention if the composition, by means of the inclusion therein of mixtures of perfumery ingredients, solvents, surfactants, and/or the use of an encapsulation medium, will readily disperse or dissolve in a consumer product, without causing undesirable changes in the physical characteristics of the consumer product, such as the development of residues, that could adversely affect the delivery of a zinc carboxylate consistently and uniformly to a surface in need of treatment.
Suitable perfumery solvents include, but are not limited to isopropyl myristate, ethanol, cyclomethicone, glycol ethers, such as dipropylene glycol methyl ether (e.g. Dowanol DPM) or tripropylene glycol methyl ether (Dowanol TPM), Medium Chain Triglycerides (MCTs), such as those sold under the trade names Miglyol, e.g Miglyol 812, methyl esters of hydrogenated wood rosin, such as Hercolyn DW, isoparaffins, such as the Isopar solvents, benzyl salicylates, and cyclohexyl salicylates.
Suitable perfumery ingredients can be selected from the palette of available ingredients, and may be selected on the basis of the particular hedonic effect that is desired or any functional effect that is required, such as a malodour-reducing effect. Perfumery ingredients include but are not limited to 3,7- dimethyloct-6-enal, e.g. Citronellal; 3,7-dimethyloct-6-en-l-ol, e.g. Citronellol; 2,4-dimethylcyclohex-3- enecarbaldehyde, e.g. Cyclal C; (E)-dec-4-enal; ethyl 2-methyl butyrate; 1-phenylethyl acetate, e.g. Gardenol; (Z)-hex-3-en-l-yl acetate; hexyl acetate; isoamyl acetate; Litsea cubeba oil; Nonanal; Orange oil; Orange terpenes; prenyl acetate; 4-methyl-2-(2-methylprop-l-en-l-yl)tetrahydro-2H-pyran, e.g. Rose Oxide; 4-methylene-2-phenyltetrahydro-2H-pyran, e.g. Rosyrane super; 2,4-dimethylcyclohex-3- enecarbaldehyde; e.g. Tricyclal; 2,6,10-trimethylundec-9-enal, e.g. Adoxal; Armoise oil Morocco; 8-(sec- butyl)-5,6,7,8-tetrahydroquinoline, e.g. Bigaryl; (2E)-3-phenylprop-2-enal, e.g. Cinnamic aldehyde; (E)- 3,7-dimethylocta-2,6-dienal, e.g. Citral; ethyl caproate; l,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, e.g. Eucalyptol; Eucalyptus, e.g. globulus oil China; l-(l,2,8,8-tetramethyl-l,2,3,4,5,6,7,8- octahydronaphthalen-2-yl)ethanone, e.g. Georgywood; hexyl isobutyrate; (E)-4-(2,6,6- trimethylcyclohex-l-en-l-yl)but-3-en-2-one, e.g. Ionone beta; isobutyl isobutyrate; isobutyl quinolone; isopropyl methyl-2-butyrate; (2E,6Z)-3,7-dimethylnona-2,6-dienenitrile, e.g. Lemonile; 3,7- dimethylocta-l,6-dien-3-ol, e.g. Linalool; 2,6-dimethylhept-5-enal, e.g. Melonal; methyl amyl ketone; methyl benzoate; methyl heptenone; methyl hexyl ketone; phenyl ethyl acetate; tetrahydro myrcenol; Patchouli Oil; tridecen-2-nitrile; 6-methoxy-2,6-dimethyloctanal, e.g. Calypsone; 5-tert-butyl-2-methyl- 5-propyl-2H-furan, e.g. Cassyrane; (4E)-9-hydroxy-5,9-dimethyl-4-decenal, e.g. Mahonial; l-methyl-2-(5- methylhex-4-en-2-yl)cyclopropyl)methanol, e.g. Rosyfolia; 3-(4-isobutyl-2-methylphenyl)propanal, e.g. Nympheal; and mixtures thereof.
In particular embodiments of the invention the perfumery ingredients may comprise at least 2, at least 3, at least 4, at least 5 of the following ingredients: 3,7-dimethyloct-6-enal, e.g. Citronellal; , 3,7- dimethyloct-6-en-l-ol, e.g. Citronellol; 2,4-dimethylcyclohex-3-enecarbaldehyde, e.g. Cyclal C; (E)-dec- 4-enal; Ethyl 2-methyl butyrate; 1-phenylethyl acetate, e.g. Gardenol; (Z)-hex-3-en-l-yl acetate; Hexyl acetate; isoamyl acetate; Litsea cubeba oil; Nonanal; Orange oil; Orange terpenes; prenyl acetate; 4- methyl-2-(2-methylprop-l-en-l-yl)tetrahydro-2H-pyran, e.g. Rose Oxide; 4-methylene-2- phenyltetrahydro-2H-pyran, e.g. Rosyrane super; 2,4-dimethylcyclohex-3-enecarbaldehyde; e.g. Tricyclal; and optionally at least 2, at least 3, at least 4, at least 5 of the following ingredients: 2,6,10- trimethylundec-9-enal, e.g. Adoxal; Armoise oil Morocco; 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline, e.g. Bigaryl; (2E)-3-phenylprop-2-enal, e.g. Cinnamic aldehyde; (E)-3,7-dimethylocta-2,6-dienal, e.g. Citral; Ethyl caproate; l,3,3-trimethyl-2-oxabicyclo[2.2.2]octane, e.g. Eucalyptol; Eucalyptus, e.g. globulus oil China; l-(l,2,8,8-tetramethyl-l,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, e.g. Georgywood; Hexyl isobutyrate; (E)-4-(2,6,6-trimethylcyclohex-l-en-l-yl)but-3-en-2-one, e.g. Ionone beta; Isobutyl isobutyrate; Isobutyl quinolone; Isopropyl methyl-2-butyrate; (2E,6Z)-3,7-dimethylnona-2,6- dienenitrile, e.g. Lemonile; 3,7-dimethylocta-l,6-dien-3-ol, e.g. Linalool; 2,6-dimethylhept-5-enal, e.g. Melonal; Methyl amyl ketone; Methyl benzoate; Methyl heptenone; Methyl Hexyl Ketone; Phenyl ethyl acetate; Tetrahydro myrcenol; Patchouli Oil; Tridecen-2-nitrile; 6-methoxy-2,6-dimethyloctanal, e.g. Calypsone; 5-tert-butyl-2-methyl-5-propyl-2H-furan, e.g. Cassyrane; (4E)-9-hydroxy-5,9-dimethyl-4- decenal, e.g. Mahonial; l-methyl-2-(5-methylhex-4-en-2-yl)cyclopropyl)methanol, e.g. Rosyfolia; and 3- (4-isobutyl-2-methylphenyl)propanal, e.g. Nympheal.
Preferred perfumery ingredients include ambrofix (dodecahydro-3a,6,6,9a-tetramethyl naphtho[2,l- b]furan), radjanol (2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-en-l-ol), benzyl salicylate, cis-3- hexenyl salicylate, coumarin, cyclamen aldehyde, dihydrojasmonate, hedione (methyl dihydrojasmonate), lilial (3-(4-tert-butylphenyl)-2-methylpropanal), nympheal (3-(4-isobutyl-2- methylphenyl)propanal), methyl ionone, phenyl ethyl phenyl acetate, tetrahydrogeranyl acetate, trimofix (reaction products of acetic anhydride and l,5,10-trimethyl-l,5,9-cyclodecatriene), and tropional (3-(l,3-benzodioxol-5-yl)-2-methylpropanal).
In particular embodiments of the invention the malodour-reducing composition comprises zinc neodecoate in a mixture with a perfumery solvent, or a perfumery ingredient or a mixture thereof. More particularly, the mixture may comprise greater than 50 wt %, greater than 60 wt %, greater than 70 wt %, greater than 80 wt % of zinc neodecanoate. More particularly still, the malodour-reducing composition comprises about 80 wt % zinc neodecanoate and about 20 wt % of at least one perfumery solvent or at least one perfumery ingredient or mixtures thereof. In particular embodiments of the present invention, the malodour-reducing composition described herein above is in the form of a plurality of microparticles encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
In more particular embodiments, the malodour-reducing composition is in the form of a powder comprising a plurality of microparticles encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
In particular embodiments of the invention the microparticles contain at least 30 wt %, at least 40 wt %, at least 50 wt %, at least 60 wt %, at least 70 wt %, at least 80 wt % of zinc neodecanoate based on the total weight of the microparticles.
The malodour-reducing composition can be added to the aforementioned consumer products at levels such as to deliver an effective malodour-reducing effect onto a surface in need of treatment.
In particular embodiments of the invention, the malodour-reducing composition in the form of a powder comprising a plurality of microparticles described above can incorporated into an antiperspirant product in an amount ranging from about 1 wt % to about 50 wt %, more particularly about 1 wt % to about 20 wt %, more particularly about 1 wt % to about 10 wt %, based on the total weight of the antiperspirant product.
In particular embodiments of the invention, the zinc neodecanoate is present in an amount of 0.1 to 20 wt %, more particularly still about 0.5 to 10 wt %, more particularly still 0.5 to 5 wt %, e.g. about 4 wt %, based on the total weight of the product.
Microparticles are small particles, having diameters ranging generally from about 1 to 1000 microns. Microparticles may have variety of structures ranging from single-core (so-called core-shell microparticles) to multi-cores, and can comprise single or multilayer shells. The core material can comprise a zinc carboxylate and any other desired ingredient, such as one or more perfume ingredients or perfumery solvents, or surfactants.
Microparticles may be incorporated into a consumer product in the form of an aqueous slurry in which the microparticles are suspended. Alternatively, the microparticles may be incorporated into a consumer product in the form of a powder. Such powders can be formed by dehydrating a slurry for example by spray drying. Methods of forming microparticle slurries or dehydrated microparticles in powder format are well known in the art, and examples of such methods are disclosed in the references cited herein below, all of which are incorporated into the specification by reference.
Microparticles in powder format are particularly useful for incorporation into antiperspirant products, and particularly aerosol antiperspirant products.
Microparticles can be formed from thermosetting polymers, such as melamine formaldehyde, melamine urea formaldehyde, polyurea, polyurethane and polyacrylates. Such thermosetting polymers shells can be formed as shells by known polymerization methods, such as interfacial polymerization around droplets of core material. Examples of core shell microcapsules formed from thermosetting polymers that are useful in the preparation of encapsulated zinc carboxylates are disclosed in W02004/016234; W02006/056093; WO2007/137441; W02008/098387; W02009/100553;
W02017/001672; WO2018/197266; W02016/207180; WO2018/149775; WO2011/161229;
WO2013/092958; W02016/071151; W02016/071150; W02016/071149; W02017/085105; WO2014/064252; WO2014/064255; and W02014/032290, all of which documents are herein incorporated by reference.
Another commonplace method of forming microparticles useful in the present invention is coacervation. Coacervation is a well-known method of forming microparticles, whereby colloids are caused to form and harden around droplets of core material. So-called simple coacervation uses a single hydrocolloid, whereas complex coacervation uses two hydrocolloids. Coacervate microparticles useful in the present invention are disclosed in W02015/150370; and WO2013/068581, which documents are herein incorporated by reference.
Still further, microparticles can be formed by spray drying an emulsion comprising a zinc carboxylate and other materials desired to be encapsulated, and shell forming polymers, such as starches, modified starches, celluloses and the like. Examples of such microparticles, and methods of preparing them, are disclosed in WO2020/149192; WO2015/189296; and W02020/201258 all of which documents are herein incorporated by reference. In such starch microparticles the encapsulated material is dispersed in the form of a plurality of droplets or cores dispersed within an encapsulating polymer matrix.
In a preferred embodiment, the microparticles are core-shell microparticles. A malodour-reducing composition in the form of a plurality of core-shell microcapsules can provide superior malodour control performance compared, for example, with the aforementioned microparticles comprising a plurality of droplets or cores dispersed within an encapsulating polymer matrix.
More recently, the perfume industry has moved in the direction of biodegradable microparticles, and in particular biodegradable core-shell microparticles, that are free, or substantially free of microplastics, and such microparticles are useful to encapsulate zinc carboxylates, and more particularly zinc neodecanoate, in accordance with the present invention. Biodegradable microparticles can be formed by a process of coacervation or complex coacervation using various proteins and/or polysaccharides. Examples of biodegradable microparticles useful in the present invention are disclosed in WO2020/233887, which is herein incorporated by reference. Other examples of useful core-shell microcapsules wherein the shell comprises a hydrated polymer phase and a polymeric stabilizer comprising a thermosetting resin, and more particularly a thermosetting resin formed by the reaction of a polyfunctional isocyanate and an aminosilane are disclosed in WO 2023/020883, which core-shell microcapsules are likewise incorporated herein by reference.
An encapsulated form of zinc carboxylate can also be presented in the form of a plurality of pastilles or prills, which can be formed when the zinc carboxylate is dissolved or dispersed in a water-soluble matrix material and the resultant mixture is shaped, for example by extrudation and cutting. Alternatively, molten droplets of matrix material and zinc carboxylate can be dropped into a suitable liquid bath to harden the droplets and form prills, which can be collected by filtration. The water soluble matrix can contain a variety of materials useful in the preparation of scent booster compositions, as are generally well known in the art. An example of a suitable matrix material would be a mixture of polyethylene glycol, a filler material, and optionally a clay or a salt or mixtures thereof. Such compositions are described in US2017/226690, which is herein incorporated by reference. The zinc carboxylate, and optionally a perfume ingredient, perfumery solvent and a surfactant can be incorporated into the matrix material freely, or in an encapsulated form, as more fully described above.
Encapsulated forms of zinc carboxylate described hereinabove can also be incorporated into such water-soluble matrices.
In other embodiments of the present invention, a malodour-reducing composition may be formed by dissolving or dispersing a zinc carboxylate in an oil phase comprising a surfactant and optionally at least one perfumery ingredient and or perfumery solvent, or mixtures thereof. Whereas the zinc carboxylates are to some extent soluble or miscible in perfumery ingredients or perfumery solvents, they are practically insoluble in water. Accordingly, in order to be able to disperse an effective concentration of a zinc carboxylate in a consumer product containing water, it is necessary to present the zinc carboxylate in admixture with a surfactant.
Preferred surfactants are non-ionic surfactants. Suitable non-ionic surfactants include any of those that are commonly employed in consumer products including but not limited to roll-on deodorants, hand dish wash, surface cleaners, deodorants, and fabric care products, including but not limited to liquid and powder laundry detergents, fabric conditioners, fabric refreshers, and scent boosters. Particularly preferred non-ionic surfactants include ethoxylated fatty acids and particular those having a chain length the same as or similar to that of the zinc carboxylate employed. Examples of particularly preferred non- ionic surfactants are Lutensol TOIO or Synperonic 13/9.
In accordance with the second aspect of the invention the consumer products into which a malodour- reducing composition can be stably dissolved or dispersed include, but are not limited to, carpet spray, fabric spray, all-purpose cleaners, bathroom cleaners, kitchen cleaners, floor cleaners, hand dish wash cleaners, diapers, feminine hygiene products, cat litter, roll-on deodorants, roll-on antiperspirants, liquid soap, bar soap, body wash, detergent bars, detergent pastes/creams, detergent powder tablets, liquid detergents, liquid detergent capsules, detergent powders, fabric fresheners, scent boosters, ironing water, and liquid softeners.
In particular embodiments of the invention, the consumer product is an antiperspirant product, and more particularly an antiperspirant product in aerosol format.
In more particular embodiments of the invention there is provided an antiperspirant product comprising an antiperspirant active ingredient and a malodour-reducing composition in the form of a plurality of microparticles, and more particularly core-shell microparticles, dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
In still more particular embodiments of the invention the antiperspirant product comprises an antiperspirant active ingredient and a malodour-reducing composition in the form of a powder comprising a plurality of microparticles, and more particularly core-shell microparticles, dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof in any amounts referred to herein.
In particular embodiments of the invention the antiperspirant product contains about 0.1 wt %, more particularly 0.5 wt % and more particularly still about 1 wt %, up to about 5 wt %, more particularly up to 4 wt %, more particularly up to 3 wt %, more particularly up to 2 wt % of water based on the total weight of the product.
Antiperspirant active ingredients include aluminium salts and complexes. Useful salts and complexes include but are not limited to aluminium chlorohydrate, aluminium chlorohydrate complexes such as aluminium sesquichlorohydrate and aluminium zirconium tetrachlorohydrate glycine complex, and aluminum zirconium complexes.
In particular embodiments of the invention the antiperspirant active ingredient is present in the antiperspirant product in an amount of about 0.5 to 50 wt %, more particularly still about 0.5 to 40 wt %, still more particularly about 0.5 to 30 wt %, and more particularly still from about 0.5 to 20 wt %, based on the total weight of the product. Depending upon the particular format of an antiperspirant product, it may contain one or more additional ingredients such as an emollient, thickening or structuring agents, perfumes, propellants, pH buffering agents, humectants, additional malodour-controlling agents, skin-soothing agents, dyes or pigments, and anti-microbial agents. Examples of such additional ingredients and their inclusion level in such products are well known to the skilled person in the art. Further details of such products, their constituent ingredients and inclusion levels are disclosed, for example, in WO 2018/087148, which is hereby incorporated by reference for this purpose.
In accordance with the third aspect of the invention any of the malodour-reducing compositions described herein above can be used to stably incorporate zinc carboxylates, and in particular zinc neodecanoate, into any of the consumer product formats referred to in any of the embodiments described herein.
In a particular embodiment of the invention zinc neodecanoate can be incorporated into an antiperspirant product as defined herein in a method comprising the step of mixing zinc neodecanoate with at least one perfume ingredient or perfumery solvent and encapsulating the mixture in an encapsulating medium comprising a plurality of microparticles as described herein, and dispersing the microparticles in the antiperspirant product.
In accordance with the fourth aspect of the invention, any of the malodour-reducing compositions described in any of the embodiments referred to herein can be delivered from any of the aforementioned consumer product formats and onto a surface containing a source of malodour where it can deliver a malodour-reducing effect.
Surfaces include human or animal skin or hair, or inanimate surfaces including all manner of household surfaces such as hard surfaces, floors, bathroom and toilets, dishes, cutlery and other kitchen utensils, fabrics and the like. Malodours found on such surfaces include malodours from food, body odours, and odours from the waste of humans and animals.
Sources of malodour include, but are not limited to personal malodours such as axillary sweat, foot malodour, feminine (vaginal) malodour, scalp/hair malodour, urine malodour, food waste malodour, indoor air malodour, malodour from mould and mildew, and laundry malodour.
The invention will be further explained and illustrated with reference to the following non-limiting examples.
Example 1
(Synthesis of a melamine urea formaldehyde capsules containing a malodour-reducing composition)
A malodour reducing composition (1 wt % perfume, 19 wt % isopropyl myristate, and 80 wt % zinc neodecanoate) is encapsulated in melamine urea formaldehyde to form 1 Kg of slurry in accordance with the following method:
A reactor set to a temperature of 20°C and is charged with deionised water (600 g). Resorcinol as crosslinker (10 g); positively charged polymeric colloid stabilizer (2 g) and melamine formaldehyde precondensate (Luracoll SD) (5 g). The stirring speed is set to 400rpm. At this stage, 360 g of the malodour reducing composition (50 wt % in medium chain triglyceride) is added and dispersed in the water phase. Polymerisation is undertaken in the following manner: Formic acid (10%) is added to the slurry until the pH reaches 4, and the slurry is stirred for 1 hour at 35°C. Thereafter, the reactor temperature is increased to 90°C over a period of 1 hour.
Finally, the slurry is cooled, and the pH is adjusted with the addition of ammonia (lg) until it falls into the range of 3-5. Deionised water is finally added to bring the volume of the slurry to IL. The resultant slurry of encapsulated composition is discharged from the reactor.
The malodour reducing composition was successfully produced in the form of a slurry of microparticles.
Example 2
(Synthesis of a starch capsule containing a malodour-reducing composition)
Tap water (55.0 g) was weighed into a stainless steel beaker. Starch sodium octenyl succinate E1450 (18.7 g), starch modified Hi-Cap 100 (2.2 g) and maltodextrin Glucidex IT-19 (5.3 g) were subsequently weighed into the same beaker. The resulting mixture was first manually stirred with a stainless steel rod and then homogenized with an IKA T25 Ultra-Turrax Homogenizer at 13,500 rpm to obtain a homogeneous solution. To this resulting mixture was added the malodour reducing composition of Example 1 (17.8 g). High shear mixing was then carried out for 20-30 min at 22,000-24,000 rpm using the same Homogenizer to produce an emulsion. Dynamic light scattering was used to ensure the droplet size was between 0.5 and 2 microns.
The emulsion was subjected to spray drying using a LabPlant SD-06 Spray Dryer. The spray drying process parameters were as follows: Inlet Temperature: 190 °C; Outlet Temperature: 90 °C; peristaltic pump speed: 485 mL/h; and air flow rate: 3.7 m/s.
The resulting spray dried powder was mixed with silicon dioxide Aerosil 200 (0.5 g) in a closed mixing vessel.
A malodour-reducing composition was successfully produced in the form of a plurality of microparticles in dried powder form.
Example 3
(Synthesis of a scent booster product containing a malodour-reducing composition)
A scent booster product was prepared by blending fumed silica (Aerosil 200) @ 5 wt %, CMC (Blanose) @ 5 wt %, and sodium chloride @ 80wt. 10 wt % and the malodour reducing composition of Example 1 was added on top of the scent booster mixture and the whole was blended until a free-flowing powder is achieved.
(AEROSIL is a fumed silica (trade mark of Degussa); "Blanose" is carboxymethyl cellulose (trade mark of Hercules)).
Example 4
(Deposition of zinc neodecanoate from the scent booster product of Example 3 on to a fabric)
Use of a Metallochromic Indicator to determine deposition on fabric Eriochrome Black T is a metallochromic indicator that can be used for complexometric titration with various metal ions. It is typically used with a pHlO buffer, whereupon the solution changes from a blue colour to red when forming a complex with a metal ion, such as zinc. The proportion of complexed Eriochrome Black T will determine the shade of the indicator solution. The presence of any uncomplexed indicator will remain blue, which can mask the red coloured complexed form. Therefore, it is important to use as little of the indicator as possible to make the test as sensitive as possible. However, this needs to be carefully balanced with using enough indicator to perceive any colour. A series of solutions of zinc neodecanoate in ethanol were prepared (from 10% to 0.00001% in logarithmic steps). A further series of vials were prepared with 2mL of pH 9.41 buffer solution and lOpL of Eriochrome Black T solution (1% in ethanol). lOpL of the zinc neodecanoate solutions were added to the vials with the Eriochrome Black T solutions. The colours of the resulting solutions demonstrate that zinc neodecanoate can be detected at concentrations of 0.1% and higher, with 0.01% producing a weakly positive result.
Simulated Wash Cycle Test
10 wt % of a malodour reducing composition (zinc neodecanoate @ 10 wt % in Dowanol TPM) is added to the scent booster composition described in Example 3, and mixed thoroughly. A sample only using Dowanol TPM and the scent booster composition was also prepared. 150mg of each scent booster composition was added to 50mL of distilled water in a 60g glass bottle. Four small pieces of terry towelling (totalling 14cm2) were added to each bottle and placed on a roller for one hour.
The indicator solution was prepared by adding buffer solution (ImL, pH 9.21) and Eriochrome Black T solution (1% in ethanol) into a clear glass vials (7.5mL). One of the pieces of terry towelling from each bottle was added to separate vials containing the indicator solution. The vials were agitated and the resulting colour was recorded.
Further indicator (lOpL of 1% Eriochrome in ethanol) was added to each vial and the colours became more differentiated.
The remaining pieces of terry towelling were transferred to a fresh clear glass bottle (60mL) containing distilled water (50mL). The bottles were placed on a roller for a further hour. A piece of terry towelling was removed from each bottle and tested with the indicator solution as before (lOpL of 1% Eriochrome in ethanol, in ImL of pH9.21 buffer solution). It is still possible to differentiate the colours of the resulting solutions. This demonstrates that zinc neodecanoate is depositing onto the fabric and remaining there after rinsing.
The two remaining pieces of cloth were air dried overnight and tested using the same procedure as before. The cloth washed along with the scent booster containing zinc neodecanoate was still positive for the presence of zinc.
This experiment demonstrated that zinc neodecanoate can be deposited onto fabrics from a consumer product containing a malodour-reducing composition, and remain there after rinsing and drying.
Example 5
(Demonstration of malodour-reduction performance on fabric - trigger spray formulation)
A clear and colourless model trigger spray formulation was prepared using zinc neodecanoate (0.75 wt %), Dowanol TPM as solvent (0.25 wt %), lutensol TO 10 (9 wt %) and water (90 wt %). A control was prepared by replacing Dowanol TPM and zinc neodecanoate with diethyl phthalate (1 wt %)•
T-shirt inserts were pre-treated with the model formulation and the control. The inserts were allowed to dry and were placed into the underarm of t-shirts, which were then worn by a panel of volunteers for a whole day, without using fragranced products. Thereafter, the t-shirt inserts were olfactively assessed by a trained sensory panel for malodour intensity.
It was found that those inserts treated with the model trigger spray formulation exhibited significantly reduced malodour intensity compared with those inserts treated with the control formulation.
Example 6
(Demonstration of malodour reduction performance on fabric - Laundry tests)
A. Odour elimination on terry towelling
Preparation
Three different test compositions (1-3) were prepared according to the composition given in table 1. The samples NU67, MO48 and QC29 (lOOOpL) are applied to the centre of separate pieces of cloth (70mm x 70mm of terry towelling squares) together with 250pL of 0.006% 3-mercapto-3-methyl butan- l-ol (MMB) in Dowanol TPM as malodour. Samples ED71 and WC14 are applied to the centre of separate pieces of cloth (70mm x 70mm of terry towelling squares) without any malodour as control. Labels were attached to the top right of each piece of fabric.
Results:
The pieces of fabric were assessed by a trained panel of 15 assessors for malodour intensity using a 0- 100 scale with the control set at 70, and 1-minute gap between assessments. The samples were assessed in a randomised order (randomisation was produced using Design Express). The average intensity rating for the hidden control (NU67) was 63. The panel reliability was very good (G=0.98, phi=0.98, inter-rater reliabil ity=0.76).
Table 1: Samples and results (also Fig. 1)
Sample Test Composition Malodour Applied Perceived Malodour intensity
1% Dowanol TPM,
NU67 1 9% Synperonic 13/9, Yes 63
90% water
0.25% Dowanol TPM,
0.75% Zinc neodecanoate, MO48 2 Yes
Figure imgf000012_0001
9% Synperonic 13/9,
90% water
QC29 3 0.25% Dowanol TPM, Yes 0.75% TegoSorb Cone. 50, 59
9% Synperonic 13/9
90% water
1% Dowanol TPM,
ED71 1 9% Synperonic 13/9, No 10
90% water
0.25% Dowanol TPM,
0.75% Zinc neodecanoate,
7
WC14 2 , No
9% Synperonic 13/9,
90% water
B. Odour elimination by application of refresher spray - pre-dosed on T-shirt inserts
Methodology - Test Formulations
Two refresher sprays were formulated, one with zinc neodecanoate, the other one without it. They were prepared by mixing each ingredient in the order presented in table 2, from top to bottom.
Table 2: Composition of fabric refresher spray formulations
x Amount (%) in Amount (%)
Ingredient
+TECH in W/O
Z ->■inc neodecanoat.e 0.75
0 25 1.00 Dowanol TPM e •c 13/7 9-0 9.00
Synperom 0
90.00
Figure imgf000013_0001
Methodology - Insert Preparation The fabric inserts are pre-washed, de-sized, labelled, had poppers sewn-in and hung on a laundry drying rail. The fabric refresher formulations are applied to each T-shirt insert: 2 sprays of the formulation followed by 2 further sprays 5 minutes later. The inserts are then allowed to dry before attaching to the T-shirts, randomising which side had the technology present (+TECH) and which not (W/O) as shown in table 3. Table 3: Order used for location of each refresher spray formulation
T Shirt Left lnsert Right Insert T-Shirt No. Left Insert Right Insert No. +TECH W/0 14 W/O +TECH
W/0 +TECH 15 +TECH W/O
+TECH W/0 16 W/O +TECH
W/O +TECH 17 +TECH W/O
+TECH W/0 18 W/O +TECH
W/0 +TECH 19 +TECH W/O
+TECH W/0 20 W/O +TECH
W/O +TECH 21 +TECH W/O
+TECH W/0 22 W/O +TECH
9
W/O +TECH 23 +TECH W/O
10
+TECH W/0 24 W/O +TECH
W/0 +TECH 25 +TECH W/O
+TECH W/0
The T-shirts are then supplied to volunteers, who wear them for a working day without use of any fragranced products or deodorant. The T-shirts are then returned for assessment the following day.
Methodology - Assessment of trained sensory panel
The inserts are removed from the T-shirts and arranged around two separate tables (one for left inserts, the other for the right inserts). The trained sensory panel (n=16) assess each insert individually for malodour intensity using a 0-100 free scoring scale in a randomised order defined by the assessment sheet.
Results
23 T-shirts were returned (1 of which had not been worn, but was included as a hidden control) and were assessed by the trained sensory panel. It was noted that several of the inserts smelled of fragrance and were later removed from the results.
The reliability of the panel assessments was checked using the Panel Reliability Program (v2-8) and no assessors needed to be excluded (G=0.93, phi=0.91, inter-rater rel iability=0.47).
The malodour intensity of the pairs of T-shirt inserts with LS means below 20 were considered too low and removed. The remaining dataset was analysed by ANOVA.
The geometric mean malodour intensity was calculated for each insert, along with the standard error and difference between left and right. Perceived malodour intensity was measured and the overall results are that, with a value of 42.5, the intensity of the pre-dosed T-shirt inserts with zinc neodecanoate was lower than the intensity of the T-shirt inserts without the zinc neodecanoate having a value of 45.2.
C. Odour elimination by application of refresher spray - Post-dosed on worn T-shirt inserts
Methodology - Test Formulations
Two refresher sprays were formulated, one with zinc neodecanoate, the other one without it. They were prepared by mixing each ingredient in the order presented in table 4, from top to bottom.
Table 4: Composition of fabric refresher spray formulations
Amount (%) in Amount (%) in
Ingredient +TECH W/O
0.75
Zinc neodecanoate
0.25 1.00
Dowanol TPM
9.00 9.00
Synperonic 13/7
90.00 90.00
Water
Methodology - Insert Preparation (Before Wear)
The fabric inserts are pre-washed, de-sized, labelled, had poppers sewn-in and attached to the underarm area of white T-shirts (also pre-washed and de-sized). The T-shirts are then supplied to volunteers who wear them for a working day without use of any fragranced products or deodorant. The T-shirts are then returned for further treatment and assessment.
Methodology - Insert Preparation (After Wear)
The fabric inserts were pre-screened by a trained panel of three internal sensory assessors to ensure that there is a perceivable amount of malodour but no fragrance present on the inserts. The fabric refresher formulations are applied to the remaining inserts: approximately 4 pumps of the selected fabric refresher. A different fabric refresher is applied to either the left or right insert. The inserts are then allowed to dry before attaching to the T-shirts, randomising which side had the technology present (+TECH) and which not (W/O) as shown in table 5.
Table 5: Order used for location of each refresher spray formulation
> x Left Insert Right Insert T-Shirt No. Left Insert Right Insert T-Shirt °
No.
2 W/O +TECH 14 W/O
Figure imgf000015_0001
3 +TECH W/O 15 W/O \N/0 +TECH 16 +TECH W/° W/°
Figure imgf000016_0002
Methodology - Assessment of trained sensory panel
The inserts are allowed to dry and then arranged in pairs for olfactive assessment. The trained sensory panel assesses each insert for malodour intensity using a 0-100 free scoring scale in a randomised order defined by the assessment sheet.
Results
There were 17 pairs of T-shirt inserts assessed by the trained sensory panel (n=15).
The malodour intensity data provided by the trained internal sensory panel was checked using the Panel Reliability Program (v2-8). The results indicate that no assessors need to be excluded (G=0.93, phi=0.90, inter-rater reliabil ity=0.48).
The malodour intensity of the pairs of T-shirt inserts with LS means below 20 were considered too low and removed. The remaining dataset was analysed by ANOVA.
The geometric mean malodour intensity was calculated for each insert, along with the standard error and difference between left and right. Perceived malodour intensity was measured and the overall results are that, with a value of 37.3, the intensity of the post-dosed T-shirt inserts with zinc neodecanoate was lower than the intensity of the T-shirt inserts without the zinc neodecanoate having a value of 44.4 (Fig. 2).
D. _ Fabric Conditioner with Socks
Test Formulations
Two sets of fabric conditioners were formulated, one with zinc neodecanoate and the other one without it. The fragrance selected is a 'typical' fabric conditioner type fragrance.
Table 6: Composition of liquid fabric conditioner formulations ingredient Amount (%) Amount (%)
With Without
Zinc
Figure imgf000016_0001
- neodecanoate
5 distilled water 1 1
Fragrance
Fab Con Base 94
Methodology - Washing Socks
Sixty pairs of socks (30 male, 30 female) were separated and washed such that either the left or right were treated either with (+TECH) or without the technology (W/O) as shown in table 7. A standard wash cycle was used with un-fragranced detergent. The fabric conditioner (35g) was placed directly into the drum at the appropriate part of the wash cycle.
Table 7: Sequence used to sort socks treated with different fabric conditioner sample
Left Right
+TECH W/O
Male Socks - Odd
W/O +TECH
Male Socks - Even
W/O +TECH
Female Socks - Odd
+TECH W/O
Female Socks - Even
Methodology - Wear and Self-Assessment
The socks were provided to volunteers (naive panellists) to be worn for a working day, then assessed for fragrance and malodour (0-10 fixed scale), and the preferred socks were selected.
Results
30 pairs of male socks and 29 pairs of female socks were returned along with the assessment sheets. There was no clear difference in preference between the socks washed using the fabric conditioner with zinc neodecanoate, compared to without (16 men with, 13 men without, 15 women with, 13 women without).
Several of the socks were self-assessed as not having any malodour and were removed from the data set. The resulting dataset was used to compare the fragrance intensity and malodour intensity of the samples with and without zinc neodecanoate present. It was found that there is an indicative benefit in malodour intensity, which however is not statistically significant. There is no difference in perceived fragrance intensity (Fig. 3).
Example 7
(Demonstration of the incorporation of encapsulated zinc neodecanoate in a model aerosol base).
A model aerosol base is selected based on its transparency that enables the development of any residues to be observed. The base selected is 96 % ethanol, which allows easily observance of any precipitates that are formed. Two glass jars containing aerosol formulations (50ml) are prepared by dispersing 1 and 4 wt% of core shell capsules according to Example 1 in ethanol 96° before addition of propellant.
Another two glass jars containing aerosol formulations are prepared by dispersing 0.5 wt% and 2 wt% of the malodour-reducing composition (this time in unencapsulated form), in ethanol before addition of propellant.
The glass jars are stored at 4°C for 24h.
Upon visual inspection, the samples containing the encapsulated malodour-reducing composition remain clear, whereas a cloudy precipitate is visible in both samples containing unencapsulated malodour reducing composition. The cloudy precipitate sediments after a few hours.
The results indicate that the encapsulated composition are dispensible from a nozzle of an aerosol container to be delivered uniformly onto a surface to exert a malodour-reducing effect.
Example 8
(Demonstration of malodor control benefit of encapsulated zinc neodecanoate in an aerosol base)
A malodour-reducing composition comprising core-shell microparticles encapsulating a mixture comprising zinc neodecanoate (1 wt % perfume, 19 wt % isopropyl myristate, and 80 wt % zinc neodecanoate) was added to an aerosol base comprising a carrier, an aluminium salt antiperspirant active and residual water to produce an aerosol base (hereafter referred to as "Base 01"). The microparticle shell material comprised a thermosetting resin, formed from the reaction of an aminosilane and a polyfunctional isocyanate as described in W02023020883. The malodour-reducing composition was incorporated in Base 01 such that zinc neodecanoate was dosed at at 1.4 wt%. The aerosol base without the malodour-reducing composition was used as a control (hereafter "Control")
The testing was performed on underarm through a self-assessment study in which the Control was applied on one side of a participant's underarm while Base 01 was applied on the other underarm. A group of participants were recruited and instructed to take aerosol test products (i.e. Base 01 and Control) home for use. A test study was rolled out over a period of 1 to 2 weeks. The objective of this test was to allow self-assessment of long lasting malodour protection on underarm contributed by the test products.
This study involved 21 participants where each participant was asked to use each of the coded test products over a consecutive 2-day period. Application of test products by means of aerosol spray was made on the same underarm position (left/right side) for each product. Assessment time intervals were made at before product application, 2 hours, 4 hours post-application.
The overall perceived odour intensity was self-assessed using a 0 to 5 rating scale. Participants were instructed to smell directly the treated skin rather than through clothing worn over the treated skin in order to make an odour rating. For the evaluation stages conducted, each test product was assessed twice by each of the 21 participants, thus giving 42 assessments per test product. The participants used the following scaling:
0 - no odour, 1 - slightly weak odour, 2 - noticeable odour, 3 - quite strong odour, 4 - strong odour, 5 - very intense/strong odour. The data were analysed using an analysis of variance and multiple comparison test. The confidence level was at 95%. The results are provided in table 8, in terms of perceived malodour intensity.
Table 8: malodor control benefit of encapsulated zinc neodecanoate
Figure imgf000019_0001
"'Where the same letter is shown under "Group" there was no statistically-significant difference between the indicated figures. As evidenced above, there was significantly lower malodour intensity perceived on underarms treated with Base 01 as compared to Control, up to 4 hours duration.

Claims

We claim:
1. An antiperspirant product comprising an antiperspirant active ingredient, water and a malodour- reducing composition in the form of a plurality of microparticles dispersed in the product, the microparticles encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient.
2. An antiperspirant product according to claim 1, comprising water in an amount of about 0.1 to about 5 wt %, and more particularly about 0.5 to about 5 wt % based on the total weight of the product
3. An antiperspirant product according to claim 1 or claim 2, wherein the antiperspirant active ingredient is an aluminium-containing salt or complex.
4. An antiperspirant product according to any of the preceding claims, wherein the antiperspirant active ingredient is selected from the group consisting of aluminium chlorohydrate, aluminium chlorohydrate complexes aluminium sesquichlorohydrate and aluminium zirconium tetrachlorohydrate glycine complex, and aluminum zirconium complexes.
5. An antiperspirant product according to any of the preceding claims wherein the antiperspirant active ingredient is present in an amount of 0.5 to 50 wt % based on the total weight of the product.
6. An antiperspirant product according to any of the preceding claims wherein the malodour- reducing composition is in the form of a powder comprising a plurality of microparticles dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient, or mixtures thereof.
7. An antiperspirant product according to any of the preceding claims wherein the microparticles contain at least 30 wt % of zinc neodecanoate based on the total weight of the microparticles.
8. An antiperspirant product according to any of the preceding claims wherein the malodour- reducing composition, in the form of a powder comprising a plurality of microparticles dispersed in the product and encapsulating zinc neodecanoate and optionally at least one perfumery solvent or perfumery ingredient or mixtures thereof, is incorporated into the antiperspirant product in an amount ranging from range of about 1 wt % to about 50 wt %.
9. An antiperspirant product according to any of the preceding claims wherein zinc neodecanoate is present in an amount of 0.1 to 20 wt % based on the total weight of the product.
10. An antiperspirant product according to any of the preceding claims wherein the microparticles are in the form of core-shell microparticles.
11. An antiperspirant product according to claim 11, wherein the shell is formed of a hydrated polymer phase and a polymeric stabilizer comprising a thermosetting resin, wherein the thermosetting resin is the reaction product of a polyfunctional isocyanate and an aminosilane.
12. A method of incorporating zinc neodecanoate into an antiperspirant product as defined in any of the preceding claims, the method comprising the step of mixing zinc neodecanoate with at least one perfume ingredient or perfumery solvent; encapsulating the mixture in an encapsulating medium comprising a plurality of microparticles; and dispersing the microparticles in the antiperspirant product.
13. A method of delivering a malodour counteracting effect to a surface containing a source of malodour, said method comprising the step of applying the antiperspirant product according to the any of the claims 1 through 11 onto human skin or hair.
14. A method according to claim 13 wherein the malodour is a body odour or a scalp malodour.
PCT/EP2024/066361 2023-06-15 2024-06-13 Improvements in or relating to organic compounds Ceased WO2024256539A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP24732957.6A EP4727515A1 (en) 2023-06-15 2024-06-13 Improvements in or relating to organic compounds
CN202480039342.6A CN121311213A (en) 2023-06-15 2024-06-13 Improvements in or related to organic compounds
KR1020267001283A KR20260022456A (en) 2023-06-15 2024-06-13 Improvements in or related to organic compounds
MX2025014653A MX2025014653A (en) 2023-06-15 2025-12-05 Improvements in or relating to organic compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23179473 2023-06-15
EP23179473.6 2023-06-15

Publications (1)

Publication Number Publication Date
WO2024256539A1 true WO2024256539A1 (en) 2024-12-19

Family

ID=86852001

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2024/066361 Ceased WO2024256539A1 (en) 2023-06-15 2024-06-13 Improvements in or relating to organic compounds

Country Status (5)

Country Link
EP (1) EP4727515A1 (en)
KR (1) KR20260022456A (en)
CN (1) CN121311213A (en)
MX (1) MX2025014653A (en)
WO (1) WO2024256539A1 (en)

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016234A1 (en) 2002-08-14 2004-02-26 Quest International Services B.V. Compositions comprising encapsulated material
WO2006056093A1 (en) 2004-11-24 2006-06-01 Givaudan Sa Granulated composition
WO2007137441A1 (en) 2006-05-30 2007-12-06 Givaudan Sa Microcapsules
WO2008098387A1 (en) 2007-02-13 2008-08-21 Givaudan Sa Microcapsules
WO2009100553A1 (en) 2008-02-11 2009-08-20 Givaudan Sa Product
WO2011161229A1 (en) 2010-06-25 2011-12-29 Givaudan Sa Process for producing microcapsules
WO2013068581A2 (en) 2011-11-11 2013-05-16 Givaudan Sa Toothpaste
WO2013092958A1 (en) 2011-12-22 2013-06-27 Givaudan Sa Improvements in or relating to the encapsulation of perfumes
WO2014032290A1 (en) 2012-08-31 2014-03-06 华为技术有限公司 Processing method and device for internet of things information and management control system
WO2014064255A2 (en) 2012-10-25 2014-05-01 Givaudan Sa Capsules
WO2014064252A2 (en) 2012-10-25 2014-05-01 Givaudan S.A. Process
WO2015150370A1 (en) 2014-03-31 2015-10-08 Givaudan Sa Improvements in or relating to organic compounds
WO2015189296A1 (en) 2014-06-10 2015-12-17 Givaudan Sa Dishwasher detergent fragrance composition
WO2016071149A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
WO2016071150A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
WO2016071151A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Capsule composition
WO2016207180A1 (en) 2015-06-22 2016-12-29 Givaudan Sa Improvements in or relating to encapsulated perfume compositions
WO2017001672A1 (en) 2015-07-02 2017-01-05 Givaudan Sa Microcapsules
WO2017085105A1 (en) 2015-11-18 2017-05-26 Givaudan Sa Improvements in or relating to organic compounds
US20170226690A1 (en) 2016-02-09 2017-08-10 International Flavors & Fragrances Inc. Scent booster compositions
WO2018087147A1 (en) 2016-11-10 2018-05-17 Givaudan Sa Deodorizing agent comprising zinc neodecanoate
WO2018087148A1 (en) 2016-11-10 2018-05-17 Givaudan Sa Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate
WO2018149775A1 (en) 2017-02-15 2018-08-23 Givaudan Sa Process
WO2018197266A1 (en) 2017-04-28 2018-11-01 Givaudan Sa Improvements in or relating to organic compounds
WO2020149192A1 (en) 2019-01-15 2020-07-23 株式会社 資生堂 Sunscreen cosmetic composition
WO2020201258A1 (en) 2019-04-03 2020-10-08 Givaudan Sa Fragranced composition
WO2020233887A1 (en) 2019-05-20 2020-11-26 Givaudan Sa Core-shell encapsulated composition comprising a benefit agent
WO2023020883A1 (en) 2021-08-16 2023-02-23 Givaudan Sa Improvements in or relating to organic compounds

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016234A1 (en) 2002-08-14 2004-02-26 Quest International Services B.V. Compositions comprising encapsulated material
WO2006056093A1 (en) 2004-11-24 2006-06-01 Givaudan Sa Granulated composition
WO2007137441A1 (en) 2006-05-30 2007-12-06 Givaudan Sa Microcapsules
WO2008098387A1 (en) 2007-02-13 2008-08-21 Givaudan Sa Microcapsules
WO2009100553A1 (en) 2008-02-11 2009-08-20 Givaudan Sa Product
WO2011161229A1 (en) 2010-06-25 2011-12-29 Givaudan Sa Process for producing microcapsules
WO2013068581A2 (en) 2011-11-11 2013-05-16 Givaudan Sa Toothpaste
WO2013092958A1 (en) 2011-12-22 2013-06-27 Givaudan Sa Improvements in or relating to the encapsulation of perfumes
WO2014032290A1 (en) 2012-08-31 2014-03-06 华为技术有限公司 Processing method and device for internet of things information and management control system
WO2014064255A2 (en) 2012-10-25 2014-05-01 Givaudan Sa Capsules
WO2014064252A2 (en) 2012-10-25 2014-05-01 Givaudan S.A. Process
WO2015150370A1 (en) 2014-03-31 2015-10-08 Givaudan Sa Improvements in or relating to organic compounds
WO2015189296A1 (en) 2014-06-10 2015-12-17 Givaudan Sa Dishwasher detergent fragrance composition
WO2016071149A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
WO2016071150A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Improvements in or relating to organic compounds
WO2016071151A1 (en) 2014-11-07 2016-05-12 Givaudan Sa Capsule composition
WO2016207180A1 (en) 2015-06-22 2016-12-29 Givaudan Sa Improvements in or relating to encapsulated perfume compositions
WO2017001672A1 (en) 2015-07-02 2017-01-05 Givaudan Sa Microcapsules
WO2017085105A1 (en) 2015-11-18 2017-05-26 Givaudan Sa Improvements in or relating to organic compounds
US20170226690A1 (en) 2016-02-09 2017-08-10 International Flavors & Fragrances Inc. Scent booster compositions
WO2018087147A1 (en) 2016-11-10 2018-05-17 Givaudan Sa Deodorizing agent comprising zinc neodecanoate
WO2018087148A1 (en) 2016-11-10 2018-05-17 Givaudan Sa Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate
WO2018149775A1 (en) 2017-02-15 2018-08-23 Givaudan Sa Process
WO2018197266A1 (en) 2017-04-28 2018-11-01 Givaudan Sa Improvements in or relating to organic compounds
WO2020149192A1 (en) 2019-01-15 2020-07-23 株式会社 資生堂 Sunscreen cosmetic composition
WO2020201258A1 (en) 2019-04-03 2020-10-08 Givaudan Sa Fragranced composition
WO2020233887A1 (en) 2019-05-20 2020-11-26 Givaudan Sa Core-shell encapsulated composition comprising a benefit agent
WO2023020883A1 (en) 2021-08-16 2023-02-23 Givaudan Sa Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
KR20260022456A (en) 2026-02-19
CN121311213A (en) 2026-01-09
MX2025014653A (en) 2026-01-07
EP4727515A1 (en) 2026-04-22

Similar Documents

Publication Publication Date Title
US11820960B2 (en) Compositions containing multiple populations of microcapsules
JP6320383B2 (en) Method for improving the performance of an aroma contained in a capsule
JP5202831B2 (en) Core shell type capsule
EP1656441B1 (en) Blooming soap bars
EP2397120B2 (en) Fragrance-containing core shell microcapsules
MX2007001843A (en) Stabilized liquid rinse-off compositions comprising fragranced aminoplast capsules.
EP3920875A2 (en) Improvements in or relating to organic compounds
US20250041192A1 (en) Improvements in or relating to organic compounds
US20080108542A1 (en) Perfume Compositions
WO2024256539A1 (en) Improvements in or relating to organic compounds
US20040253200A1 (en) Capsules
JP2005508209A5 (en)
JP6338936B2 (en) Liquid odor control agent
KR20250103720A (en) Treatment composition having fragrance-containing delivery particles
CN106795451A (en) Encapsulated Fragrance Substance Blends
BR112021013969B1 (en) Encapsulated composition, process for its preparation, its use, consumer product and use of a hemicellulose.
HK1090389B (en) Blooming soap bars

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24732957

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: MX/A/2025/014653

Country of ref document: MX

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112025025792

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 2501008461

Country of ref document: TH

WWE Wipo information: entry into national phase

Ref document number: 202617000915

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: MX/A/2025/014653

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 1020267001283

Country of ref document: KR

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A15-NAP-PA0105 (AS PROVIDED BY THE NATIONAL OFFICE)

WWE Wipo information: entry into national phase

Ref document number: 1020267001283

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2024732957

Country of ref document: EP

Ref document number: 2026100236

Country of ref document: RU

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 202617000915

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2024732957

Country of ref document: EP

Effective date: 20260115

ENP Entry into the national phase

Ref document number: 2024732957

Country of ref document: EP

Effective date: 20260115

WWE Wipo information: entry into national phase

Ref document number: 11202507825Q

Country of ref document: SG

WWP Wipo information: published in national office

Ref document number: 11202507825Q

Country of ref document: SG

ENP Entry into the national phase

Ref document number: 2024732957

Country of ref document: EP

Effective date: 20260115

ENP Entry into the national phase

Ref document number: 2024732957

Country of ref document: EP

Effective date: 20260115

WWP Wipo information: published in national office

Ref document number: 1020267001283

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2024732957

Country of ref document: EP